Evidence map›Paper›PMID 30370250›Full record

ArticleFrontiers in oncology2018

Interactions Between

Helga Tryggvadottir, Louise Huzell, Emma Gustbée, Maria Simonsson, Andrea Markkula, Karin Jirström, Carsten Rose, Christian Ingvar, Signe Borgquist, Helena Jernström

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 4 pooled it
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 4 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Statins and prognosis of female breast cancer: a meta-analysis.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Breast Cancer and Anaesthesia: Genetic Influence.International journal of molecular sciences · 2021
    Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Helga TryggvadottirClinical Sciences in Lund, Oncology and Pathology, Lund University, Lund, Sweden.
Louise HuzellClinical Sciences in Lund, Oncology and Pathology, Lund University, Lund, Sweden.
Emma GustbéeClinical Sciences in Lund, Oncology and Pathology, Lund University, Lund, Sweden.
Maria SimonssonClinical Sciences in Lund, Oncology and Pathology, Lund University, Lund, Sweden.
Andrea MarkkulaClinical Sciences in Lund, Oncology and Pathology, Lund University, Lund, Sweden.
Karin JirströmClinical Sciences in Lund, Oncology and Pathology, Lund University, Lund, Sweden.
Carsten RoseCREATE Health and Department of Immunotechnology, Lund University, Lund, Sweden.
Christian IngvarClinical Sciences in Lund, Surgery, Lund University and Skåne University Hospital, Lund, Sweden.
Signe BorgquistClinical Sciences in Lund, Oncology and Pathology, Lund University, Lund, Sweden.
Helena JernströmClinical Sciences in Lund, Oncology and Pathology, Lund University, Lund, Sweden.
Lund University · SESkåne University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple clinical trials investigate statins' effects in breast cancer. The

Indexed as

ABCB1 genotypebreast cancerHMG-CoA reductaseimmunohistochemistrypharmacogeneticsstatins

Identifiers

PMID30370250
PMCPMC6194198
OpenAlexW2909333847

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.